TLDR A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.
A 42-year-old African-American woman with a 5-year history of central centrifugal cicatricial alopecia (CCCA), a type of hair loss common in African-American women, showed significant hair regrowth after a two-month trial of baricitinib, a Janus Kinase (JAK) inhibitor. The patient had previously been treated with various medications, including oral doxycycline, oral minoxidil, topical halcinonide, and monthly triamcinolone injections, but her condition repeatedly worsened when the injections were extended beyond once a month. After two years, inflammation symptoms returned despite treatment adherence. The patient was then put on a trial of baricitinib, and after one month, her symptoms resolved. After two months, hair regrowth was noted in the area of her scalp affected by CCCA. This case suggests that JAK inhibitors like baricitinib could potentially be effective treatment options for CCCA, although further research is needed to understand their role in the disease's pathogenesis.
148 citations,
March 2022 in “The New England Journal of Medicine” Baricitinib was effective in treating alopecia areata in two major trials.
24 citations,
January 2020 in “JAAD Case Reports” Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.
95 citations,
February 2019 in “The New England Journal of Medicine” Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.
75 citations,
March 2009 in “Journal of The American Academy of Dermatology” CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.
February 2024 in “PloS one” Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.
May 2023 in “Journal of Clinical Medicine” New understanding and treatments for hair loss are improving, but more research is needed.
1 citations,
June 2023 in “Genes” Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.
2 citations,
June 2016 in “Dermatologic Clinics” Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.
November 2024 in “SKIN The Journal of Cutaneous Medicine” Visual signs are crucial for accurately diagnosing and treating different types of hair loss in Black patients.